UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 22, 2026
Sale
Calculated transaction value
$305.36K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 21, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$563.49
Oct 21, 2026
First close after public filing
$587.5
Oct 23, 2026
Return after filing · so far
-0.86%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 550 shares @ $555.19
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000169
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.44M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Oct 21, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $415.52K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $705.97K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $540.04K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $107.43K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $315.49K |
| United Therapeutics Corp UTHR Current | Sale | Oct 21, 2026 | $305.36K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $948.43K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $433.64K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $271.37K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $459.61K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $25.42K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $634.81K |
| United Therapeutics Corp UTHR | Sale | Oct 21, 2026 | $112.29K |
| United Therapeutics Corp UTHR | Exercise | Oct 21, 2026 | $0 |